Chronic hepatitis B infections on the rise since 2008
In 2017, the majority (58%) of the almost 27 000 newly reported hepatitis B cases in the European Union and European Economic Area were classified as chronic infections. This follows a consistent upward trend in reported chronic hepatitis B cases since 2008.
World AIDS Day 2018: Know the epidemic, shape the response
The tools to end new HIV infections and AIDS exist. The knowledge on how to use them is agreed upon. Nevertheless late diagnosis of HIV remains a challenges across the European Union and European Economic Area.
Marking European Testing Week: ECDC issues integrated hepatitis and HIV testing Guidance
To mark European Testing Week from 23 to 30 November 2018, ECDC publishes its new Guidance on integrated viral hepatitis and HIV testing.
The benefits of HIV treatment: undetectable means you do not pass on the virus
Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.
ECDC Expert meeting on non-pharmaceutical countermeasures for Pandemic flu
The meeting focused on the evidence base for the revision of the updated “Guide to public health measures to reduce the impact of influenza pandemics in Europe”, with a specific emphasis on non-pharmaceutical countermeasures for pandemic flu.
Course on “Control of multidrug-resistant micro-organisms (MDROs) in health care settings”
The main objective of the course was to strengthen capacity in EU Member States for control of healthcare-associated infections due to multidrug-resistant organisms (MDROs) in acute health care settings and to promote the broadest possible implementation of appropriate methods.
Public consultation on strengthening cooperation against vaccine-preventable diseases
The European Commission had an ongoing open public consultation on ‘strengthened cooperation against vaccine-preventable diseases’ which ran until 15 March 2018. The objective of this consultation was to collect the views and input of citizens, administrations, associations and other relevant organisations to feed into the process of drafting a proposal for a Council Recommendation to be adopted in mid-2018.